North Carolina GLP-1 Prescription Charges: Unlicensed Practice Risks

A North Carolina woman is facing multiple felony charges after authorities say she prescribed GLP-1 medications without a medical license, a case that underscores the risks patients face when seeking popular weight-loss drugs outside proper medical channels.

Priscilla Ann Hendrix was arrested on July 8, 2026, during a traffic stop by the Buncombe County Sheriff's Office. The arrest came after a community complaint in 2025, according to authorities. Court records show Hendrix is charged with five counts of practicing medicine without a license and five counts of obtaining property by false pretense.

GLP-1 Prescription Fraud Case: How the Alleged Scheme Worked

Warrants allege that Hendrix forged GLP-1 prescriptions by indicating she was a nurse practitioner certified (NP-C) medical provider or by using the name of another NP-C medical provider on the prescription. The forged prescriptions were written beginning in July 2025, and at least two patients paid Hendrix for them, according to the warrants.

Hendrix was released from the Buncombe County Detention Center on a $60,000 bond.

“We appreciate the community members bringing their concerns forward in this matter,” BCSO District 2 Captain Chris Stockton said in a statement. “We appreciate the work of IGRANT to fully investigate those concerns and bring charges.”

Patient Safety Risks in the GLP-1 Boom

The case highlights a growing concern as demand for GLP-1 drugs — originally developed for diabetes but now widely used for weight loss — has created a market where unlicensed actors may try to profit. GLP-1 medications require a prescription because they are potent drugs that can cause side effects and interact with other medications. A licensed medical provider must evaluate a patient's health history, current medications, and risk factors before prescribing.

When someone forges a prescription or poses as a medical provider, patients receive no such evaluation. They may receive the wrong dosage, a counterfeit drug, or a medication that is dangerous for their specific health profile. The two patients who paid Hendrix for prescriptions, according to warrants, had no way to verify her credentials or the legitimacy of the drugs they received.

This case is not an isolated incident. Across the country, law enforcement and medical boards are seeing an uptick in complaints related to GLP-1 prescribing, driven by the drugs' popularity and high out-of-pocket costs. Patients eager to lose weight may turn to online sources, social media contacts, or individuals who promise faster access without the wait for a doctor's appointment.

Regulatory Oversight and Community Reporting

The Buncombe County Sheriff's Office credited a community complaint in 2025 with initiating the investigation. That complaint led to the involvement of IGRANT, a task force that investigates fraud and illegal activity. The case shows how local law enforcement and specialized units can work together to address unlicensed medical practice, even when the alleged crimes involve prescription drugs rather than street drugs.

For patients, the lesson is clear: verify that any person prescribing medication is a licensed medical provider. State medical boards maintain online license verification tools. Patients should also be wary of anyone who asks for payment directly for a prescription, especially if they are not seen in a licensed clinic or telehealth platform.

The North Carolina case also raises questions about how telehealth and online prescribing platforms verify credentials. While legitimate telemedicine companies employ licensed providers and follow state regulations, the barrier to entry for bad actors remains low. A forged prescription can be printed on a home computer, and payment can be collected through peer-to-peer apps.

Broader Implications for the Weight-Loss Drug Market

GLP-1 drugs have become a multibillion-dollar market, and their popularity shows no signs of slowing. As more patients seek these medications, the potential for fraud and unlicensed prescribing will likely grow. State medical boards and law enforcement agencies are playing catch-up, but the case in North Carolina demonstrates that community vigilance remains a critical component of patient safety.

For now, the five counts against Hendrix serve as a warning: practicing medicine without a license is a serious crime, and those who attempt to profit from the GLP-1 boom outside the law face felony charges. Patients, meanwhile, should remember that a legitimate prescription comes from a licensed provider after a proper medical evaluation — not from a stranger promising a shortcut.